ARTICLE | Company News
Rigel Inc., Novartis Pharma AG deal
November 1, 1999 8:00 AM UTC
Rigel will use its functional genomics technology over five years to identify and validate small molecule, orally active drug targets that mediate functions of B cells involved in autoimmune diseases....